Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Alba

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2018
Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-studyJ L Ethier, A Ocaña, A Rodríguez Lescure, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 17, 2018
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudyA J Templeton, Á Rodríguez-Lescure, A Ruíz, et al.
Breast (Edinburgh, Scotland)|June 13, 2026
Association between antibiotic use and pathologic response to neoadjuvant chemotherapy in breast cancer: a multicentre retrospective cohort studyM Zalabardo, I Fernández, A Girona, et al.
ESMO Open|October 1, 2024
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES studyÁ Guerrero-Zotano, J M Pérez-García, M Ruiz-Borrego, et al.
European Urology|December 13, 2002
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG)J R Germà-Lluch, X Garcia del Muro, P Maroto, et al.
Journal of Mammary Gland Biology and Neoplasia|November 8, 2024
Gestational breast cancer: distinctive molecular and clinico-epidemiological featuresJ R de la Haba-Rodríguez, P Mínguez, F Rojo, et al.
Communications Engineering|January 8, 2025
PlomBOX: a low cost bioassay for the sensitive detection of lead in drinking waterA Dias, M Alvarez, Y Gándola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2021
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARLM Martin, C Zielinski, M Ruiz-Borrego, et al.
Psycho-Oncology|March 3, 2018
Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across SpainI Esteban, M Vilaró, E Adrover, et al.
British Journal of Cancer|August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancerA Prat, A Lluch, J Albanell, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2018
Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-studyJ L Ethier, A Ocaña, A Rodríguez Lescure, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 17, 2018
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudyA J Templeton, Á Rodríguez-Lescure, A Ruíz, et al.
Breast (Edinburgh, Scotland)|June 13, 2026
Association between antibiotic use and pathologic response to neoadjuvant chemotherapy in breast cancer: a multicentre retrospective cohort studyM Zalabardo, I Fernández, A Girona, et al.
ESMO Open|October 1, 2024
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES studyÁ Guerrero-Zotano, J M Pérez-García, M Ruiz-Borrego, et al.
European Urology|December 13, 2002
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG)J R Germà-Lluch, X Garcia del Muro, P Maroto, et al.
Journal of Mammary Gland Biology and Neoplasia|November 8, 2024
Gestational breast cancer: distinctive molecular and clinico-epidemiological featuresJ R de la Haba-Rodríguez, P Mínguez, F Rojo, et al.
Communications Engineering|January 8, 2025
PlomBOX: a low cost bioassay for the sensitive detection of lead in drinking waterA Dias, M Alvarez, Y Gándola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2021
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARLM Martin, C Zielinski, M Ruiz-Borrego, et al.
Psycho-Oncology|March 3, 2018
Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across SpainI Esteban, M Vilaró, E Adrover, et al.
British Journal of Cancer|August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancerA Prat, A Lluch, J Albanell, et al.
Pageof 12